Thymidylate Synthase and 5-Fluorouracil Sensitivity in Cancer Cells
Author Information
Author(s): J-F Mirjolet, M Barberi-Heyob, J-L Merlin, S Marchall, M-C Etienne, G Milano, P Bey
Primary Institution: Centre Alexis Vautin, Laboratoire de Recherche en Oncooge, France; Centre Antoine Lacassagne, Laboratoire d'Oncopharmacologie, France
Hypothesis
The study investigates the relationship between thymidylate synthase expression and activity, S-phase parameters, and sensitivity to 5-fluorouracil in human cancer cell lines.
Conclusion
Cell cycle parameters like S-phase duration and labelling index are better predictors of 5-fluorouracil sensitivity than thymidylate synthase expression or activity.
Supporting Evidence
- No significant correlation was found between S-phase parameters and thymidylate synthase gene expression or activity.
- A statistically significant correlation was observed between labelling index and S-phase duration with 5-fluorouracil sensitivity.
- Cell lines with shorter doubling times exhibited significantly higher sensitivity to 5-fluorouracil.
Takeaway
This study looked at how cancer cells respond to a drug called 5-fluorouracil and found that how fast the cells are growing is more important than a specific protein level in predicting their response.
Methodology
The study evaluated six human cancer cell lines for thymidylate synthase and dihydropyrimidine dehydrogenase activity, S-phase fraction, labelling index, and S-phase duration over a period of 7 days.
Limitations
The study only included six cell lines and did not account for other potential factors influencing 5-FU sensitivity.
Participant Demographics
The cell lines represented various types of cancers including squamous cell carcinoma of the upper aerodigestive tract, breast, and head and neck cancers.
Statistical Information
P-Value
0.0007
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website